Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT01523015Phase 2/3Unknown
Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction
Adenocarcinoma of the Gastroesophageal Junction
Principalinvestigator

Research Network

Collaboration Network

14 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Second Department of General & Gastrointestinal Surgery & Surgical Oncology of the Alimentary Tract, Medical University of Lublin

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Yan Sun, MD

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Moderately Similar
4 trials

Shared therapeutic areas:

Adenocarcinoma of the Gastroesophageal Junction
Similarity Score30%

Vincent Chung

City of Hope Medical Center

Moderately Similar
9 trials

Shared therapeutic areas:

Adenocarcinoma of the Gastroesophageal Junction
Similarity Score30%

Arthur Blackstock

Wake Forest University Health Sciences

Moderately Similar
3 trials

Shared therapeutic areas:

Adenocarcinoma of the Gastroesophageal Junction
Similarity Score30%

Andreas Kaubisch

Montefiore Medical Center

Moderately Similar
2 trials

Shared therapeutic areas:

Adenocarcinoma of the Gastroesophageal Junction
Similarity Score30%

Allyson Ocean

Montefiore Medical Center

Moderately Similar
3 trials

Shared therapeutic areas:

Adenocarcinoma of the Gastroesophageal Junction
Similarity Score30%

Aminah Jatoi, MD

Mayo Clinic

Moderately Similar
29 trials

Shared therapeutic areas:

Adenocarcinoma of the Gastroesophageal Junction
Similarity Score30%

Steven R. Alberts, MD

Mayo Clinic

Moderately Similar
14 trials

Shared therapeutic areas:

Adenocarcinoma of the Gastroesophageal Junction
Similarity Score30%

Jing Huang, MD

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Moderately Similar
3 trials

Shared therapeutic areas:

Adenocarcinoma of the Gastroesophageal Junction
Similarity Score30%

Clare Shaw, Phd

Royal Marsden Hospital NHS Foundation Trust

Moderately Similar
2 trials

Shared therapeutic areas:

Adenocarcinoma of the Gastroesophageal Junction
Similarity Score30%

Syma Iqbal, MD

University of Southern California

Moderately Similar
5 trials

Shared therapeutic areas:

Adenocarcinoma of the Gastroesophageal Junction
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01523015Phase 2/3PrincipalInvestigator

Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction

Adenocarcinoma of the Gastroesophageal Junction
Unknown

All 1 trials loaded